Allogenic Mesenchymal Stem Cells (MSV)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogenic Mesenchymal Stem Cells (MSV), covering 2024-04-29 to 2024-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) [Phase 1, Phase 2]